Clinical Trial: Study Protocol: The Efficacy of Mushroom to Reduce Cognitive Decline in At-Risk Middle-aged Adults and Young-olds Living in the Community

U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07775833) titled 'Study Protocol: The Efficacy of Mushroom to Reduce Cognitive Decline in At-Risk Middle-aged Adults and Young-olds Living in the Community' on July 21.

Brief Summary: The investigator's objective is to explore the definitive evidence of mushroom on cognitive functions among at-risk middle-aged and young-olds.

The investigator carefully designed a randomized controlled trial (RCT) to assess the role of mushrooms in promoting cognitive functioning among around 600 middle-aged adults and young-olds.

Participants were selected based on specific inclusion criteria, such as being community-living adults aged 45-80 years with a family his...